Loading Events

« All Events

2nd Annual Neuropsychiatric Drug Development

July 23 - July 25

Develop Clinically Transformative Neuropsychiatric Therapeutics

Built with thought-leaders at Sage Therapeutics, Janssen and Lundbeck the 2nd Annual Neuropsychiatric Drug Development Summit (NPD) will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs.

With an emphasis on depressive disorders, this industry defining meeting will

–          Investigate ketamine’s effects on opioid receptors in the brain

–          Decipher which biomarkers are a predictor of patient response rate

–          Share advances in clinical trial design to overcome challenges associated with placebos

Uniting 90+ drug developers from all corners of the world, NPD will be your opportunity to discuss, in depth, the challenges with preclinical models, precision medicine and target selection that have been stifling the progress of your neuropsychiatric drug development.

Join your peers at NPD to stride towards developing clinically transformative neuropsychiatric drugs.

Details

Start:
July 23
End:
July 25
Website:
https://ter.li/8hz3he

Venue

Wyndham Boston Beacon Hill
5 Blossom St, Boston, MA 02114, USA

Organizer

Hanson Wade
Phone:
+1 617 455 4188
Email:
info@hansonwade.com

To ensure you get the best experience on our website, we use cookies to analyze traffic and for ads measurements purposes including for serving Industry-based ads. By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close